BioPlan Associates

Delivering Actionable Knowledge

  • Services
    • Market Sizing and Forecasting
    • New Product Development
      • New Technology BETA Evaluation
    • Pricing & Value Quantification
    • Voice of Customer
    • Competitive Landscape
    • Database Services
  • Typical Engagements
  • Resources
    • Market Databases
      • Top1000bio
      • Single Use Systems
      • Top200 Cell Gene
      • Top300Bio CDMO
      • Top 100 China Online Directory Database
      • Biopharmaceuticals in the US and European Markets
    • Podcasts
    • Presentations
    • Publications
      • Books and Studies
        • Summary: Global Bioprocessing Trends 2026
        • Advances in BioPharma in China
        • Advances in BioPharma in India
        • Advances in Large-Scale Biomanufacturing
        • Biopharma Mfg Capacity and Production
        • Biopharmaceuticals in the U.S. and European Markets
        • China Biomanufacturing Comparative Analysis
        • China Biopharma Distributors
        • China CMO
        • China Top 60
        • Expression Systems
        • India Top 60
        • QG Biofuels
        • QG Clinical Trials
        • QG Middle East
      • Articles
      • Webcasts
      • White Papers
      • Newsletters
  • About
    • Who We Are
    • Press Releases
    • Partners
    • Careers
      • Staffing Solutions
    • Clients
  • Contact

New Technology BETA Evaluation

New Product Beta Testing Services in Bioprocessing

BioPlan Associates, Inc. provides specialized beta testing services for new products intended for the biopharmaceutical manufacturing sector. Our expertise supports innovators in moving their new devices and technologies from the R&D phase into operational environments where rigorous, real-world evaluation can occur.

By facilitating access to bioprocess facilities that are prepared to conduct beta testing, we help bridge the gap between New Product Development and commercial adoption. The data and user feedback generated through these evaluations are essential for determining whether a new product meets industry and facility standards. This process plays a critical role in building the evidence necessary for peer-level review and broader adoption in the bioprocessing community.

Challenges of Introducing Innovation in BioManufacturing

Biopharmaceutical manufacturing operates within a highly regulated environment, which significantly slows the process of introducing innovative products and devices. While bioprocess professionals are constantly seeking advancements that enhance efficiency, boost productivity, or reduce costs, the journey to market for new products remains arduous. Even when a device offers clear improvements or increased effectiveness, overcoming the inertia and barriers to implementation can be daunting.

These challenges are not limited to newcomers or startups entering the sector. Established companies with years of industry experience are often surprised by the complexities involved in getting their innovations tested. With over 2,000 global bioprocess facilities, gaining access for product evaluation and testing is a significant hurdle, regardless of the innovator's background or reputation.

Importance of Evaluation and Testing in Adoption

A critical initial step in the adoption of any innovation is to thoroughly evaluate and test whether the new product or device is truly fit for its intended purpose. This process involves confirming that the innovation performs as claimed within the specific systems and environments of its users. Through real-world testing and assessment, evaluators are able to generate valuable data and real-world use cases. These outcomes serve as essential components in the industry's peer-level review process, helping determine whether a new product is genuinely worthy of further consideration or broader evaluation by others.

Role of Test Data and BioPlan’s Approach to Beta Testing

Obtaining test data—whether developed internally or sourced from peer facilities—is essential for the successful adoption of any innovation. Without this data, it is virtually impossible to move an innovation forward in the industry.

Comprehensive Beta Testing Services

BioPlan offers a complete suite of services designed to transition innovations from the research and development phase into the hands of facilities equipped and willing to conduct beta testing. This helps ensure that innovations are thoroughly evaluated in real-world settings.

Why Choose BioPlan?

As an independent third-party manager, BioPlan serves as a buffer between the sponsor and the evaluator. By managing the relationship, BioPlan shields the sponsor from the necessary encouragement and, at times, assertive scheduling and project management that beta testing often requires. If a sponsor’s marketing or sales team oversees beta testing, it can strain the relationship with the evaluator—sometimes to the extent that evaluators may avoid further communication. Direct pressure from the sponsor can lead testers to disengage, which inevitably delays the process and can negatively impact the outcome.

Maintaining Simplicity in Testing

It is critical to keep the testing process as straightforward as possible. There may be temptations to broaden the scope of testing; however, BioPlan’s responsibility is to ensure the project stays well-managed, on track, and remains simple. Even seemingly minor additions outside the original scope can jeopardize the entire project.

Impact of Relationship Management

The quality and timeliness of the results generated during beta testing are often influenced by the relationship established between the sponsor and the evaluator. Effective project management is imperative to guarantee timely data delivery, foster collaborative research processes, and ensure compliance with all necessary standards.

Protecting Sponsor Reputation

With BioPlan overseeing the evaluation relationship, sponsors maintain a positive reputation with prospective buyers. This professional management helps prevent any negative perceptions that could arise from direct or overly assertive sponsor involvement.

 

Fostering a Productive Evaluator-Sponsor Relationship

Mutual Respect and Benefit

It is essential that both beta testers and evaluators recognize the importance of their partnership. This relationship is mutually beneficial and demands a level of respect and commitment from both parties. Evaluators should be treated with the utmost consideration, acknowledging their expertise and value. At the same time, evaluators must appreciate the time, resources, and effort invested by the sponsor. Both sides play critical roles in ensuring the success of the beta testing process.

Expectations for Evaluators

Evaluators are expected to provide data promptly and to maintain the agreed-upon standards of quality. While evaluators are often occupied with numerous responsibilities, their ability to consistently deliver reliable and timely results is crucial for the progression of the evaluation process. Recognizing their busy schedules, it is important to anticipate potential delays and understand that even well-intentioned evaluators face everyday challenges that may impact timelines.

 

BioPlan’s Role in Streamlining the Process

BioPlan is dedicated to making the evaluation experience as seamless and enjoyable as possible. By facilitating communication and managing logistics, BioPlan helps reduce obstacles and promotes a positive atmosphere for all participants. This ensures that the process is efficient and rewarding for both evaluators and sponsors.

Supporting Evaluators for Effective Outcomes

For evaluations to produce meaningful results, evaluators must feel personally supported and valued throughout the process. While it is necessary to uphold rigorous testing protocols, the process should be straightforward and not perceived as an excessive burden. If evaluators view the testing as too demanding, internal pressures can lead to delays and hinder progress. Maintaining a supportive and manageable environment encourages timely and high-quality participation.

Our Team in the News

Donnie E. Hubert, Senior Director, Operations and Research Projects

Donnie Hubert has extensive experience in marketing and healthcare research, and has implemented strategies for network development and operational oversight. She has expertise in Subject Matter Expert recruiting for research analyses, industry network management, and the production and editing of industry reports and newsletters. In her current role, she is responsible for the management of […]

Katrina Cordovado, MBDC, Director, Research

Katrina manages primary research initiatives examining technology adoption, materials selection, and capacity trends across the industry. She creates global biomanufacturing databases, market reports, and designs and executes industry studies that translate end-user insights into actionable market intelligence for biopharma companies, CDMOs, and technology suppliers. Her research focus includes market demand, scalability, supply chain considerations, and […]

Advances in Biopharmaceutical Technology in China, 2nd ed.

International Biopharma Spotlight   Society for Industrial Microbiology and Biotechnology and… LEARN MORE

News and Announcements

China Biopharma Distributors

NEW! Directory: Top 60 Distributors of Bioprocessing Supplies in China: Opportunities for Global Biopharma Suppliers to Find and Manage Local Distributors in China   Comprehensive China Biopharmaceutical Equipment and Suppliers Distributors Directory 2020 provides detailed profiles of China’s Equipment and Supply Distributors industry. Competitive landscape in China’s bioprocess equipment and consumables segment, with comprehensive information on […]

China CMO

NEW! Growth of Biopharmaceutical Contract Manufacturing Organizations in China: An In-depth Study of Emerging Opportunities Comprehensive In-depth Study provides detailed analysis of the CMO industry, its recent development and trends. Profiles of China’s Contract Manufacturing Organizations (CMOs) and Contract Development Manufacturing Organizations (CDMOs), including their capacity, history, products, scale, management, business focus, products, R&D, business and […]

Advances in Biopharmaceutical Technology in India

Donec vitae sapien ut libero venenatis faucibus. Donec elit libero, sodales nec, volutpat a, suscipit non, turpis. Donec id justo.

Our Team in the News

Directory of Top 60 Biopharmaceutical Manufacturers in China

Quisque ut nisi. Fusce fermentum odio nec arcu. Fusce vel dui. Etiam imperdiet imperdiet orci. Praesent egestas neque eu enim.

Advances in Biopharmaceutical Technology in India

Donec vitae sapien ut libero venenatis faucibus. Donec elit libero, sodales nec, volutpat a, suscipit non, turpis. Donec id justo.

China Biopharma Distributors

NEW! Directory: Top 60 Distributors of Bioprocessing Supplies in China: Opportunities for Global … LEARN MORE

China CMO

NEW! Growth of Biopharmaceutical Contract Manufacturing Organizations in China: An In-depth Study of … LEARN MORE

Advances in Biopharmaceutical Technology in India

International Biopharma Spotlight Advances in Biopharmaceutical Technology in India A Society for … LEARN MORE

Advances in Biopharmaceutical Technology in China, 2nd ed.

International Biopharma Spotlight   Society for Industrial Microbiology and Biotechnology and … LEARN MORE

China CMO

NEW! Growth of Biopharmaceutical Contract Manufacturing Organizations in China: An In-depth Study of Emerging … LEARN MORE

Directory of Top 60 Biopharmaceutical Manufacturers in China

BioPlan’s Directory of Top 60 Biopharmaceutical Manufacturers in China Completely updated, comprehensive Top 60 D … LEARN MORE

Advances in Biopharmaceutical Technology in India

International Biopharma Spotlight Advances in Biopharmaceutical Technology in India A Society for Industrial … LEARN MORE

A Quick Guide to Clinical Trials

  A Quick Guide to Clinical Trials,  2nd Ed. -  This book provides a unique view of the clinical … LEARN MORE

Advances in Biopharmaceutical Technology in China, 2nd ed.

International Biopharma Spotlight   Society for Industrial Microbiology and Biotechnology and BioPlan … LEARN MORE

China Biopharma Distributors

NEW! Directory: Top 60 Distributors of Bioprocessing Supplies in China: Opportunities for Global Biopharma … LEARN MORE

BioPlan Associates
ONE RESEARCH CT., STE. 450
ROCKVILLE, MD 20850

Sign Up For News and Updates

Tel: 301-921-5979
info@bioplanassociates.com